BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35644576)

  • 1. A clinical analysis on functioning pancreatic neuroendocrine tumors (focusing on VIPomas): a single-center experience.
    Murakami M; Fujimori N; Matsumoto K; Ohno A; Teramatsu K; Takamatsu Y; Takeno A; Ueda K; Oono T; Ito T; Ogawa Y
    Endocr J; 2022 Oct; 69(10):1201-1209. PubMed ID: 35644576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic and Management Challenges in Vasoactive Intestinal Peptide Secreting Tumors: A Series of 15 Patients.
    Angelousi A; Koffas A; Grozinsky-Glasberg S; Gertner J; Kassi E; Alexandraki K; Caplin ME; Kaltsas G; Toumpanakis C
    Pancreas; 2019 Aug; 48(7):934-942. PubMed ID: 31268974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypokalemic rhabdomyolysis due to watery diarrhea, hypokalemia, achlorhydria (WDHA) syndrome caused by vipoma.
    Kibria R; Ahmed S; Ali SA; Barde CJ
    South Med J; 2009 Jul; 102(7):761-4. PubMed ID: 19488018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of vasoactive intestinal peptide-secreting tumor (VIPoma) arising from MEN1 inactivation which recurred 15 years after the initial resection.
    Sakurai M; Wakabayashi T; Kondo Y; Ikeda E; Watanabe K; Takei A; Okazaki H; Okada K; Ebihara K; Kakiuchi N; Ogawa S; Fukushima N; Ishibashi S
    Endocr J; 2023 Jun; 70(6):573-579. PubMed ID: 36889692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological data and treatment modalities for pancreatic vipomas: a systematic review.
    Schizas D; Mastoraki A; Bagias G; Patras R; Moris D; Lazaridis II; Arkadopoulos N; Felekouras E
    J BUON; 2019; 24(2):415-423. PubMed ID: 31127985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Verner-Morrison syndrome: a case study].
    Halászlaki C; Horváth H; Kiss L; Takács I; Speer G; Nagy Z; Winternitz T; Dabasi G; Zalatnai A; Patócs A; Lakatos P
    Orv Hetil; 2010 Jul; 151(27):1111-4. PubMed ID: 20558361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasoactive Intestinal Peptide-Secreting Tumors: A Review.
    Siddappa PK; Vege SS
    Pancreas; 2019 Oct; 48(9):1119-1125. PubMed ID: 31609932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic VIPomas from China: Case reports and literature review.
    Chen C; Zheng Z; Li B; Zhou L; Pang J; Wu W; Zheng C; Zhao Y
    Pancreatology; 2019 Jan; 19(1):44-49. PubMed ID: 30391116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pancreatic VIPomas: subject review and one institutional experience.
    Ghaferi AA; Chojnacki KA; Long WD; Cameron JL; Yeo CJ
    J Gastrointest Surg; 2008 Feb; 12(2):382-93. PubMed ID: 17510774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Verner-Morrison syndrome. Literature review.
    Belei OA; Heredea ER; Boeriu E; Marcovici TM; Cerbu S; Mărginean O; Iacob ER; Iacob D; Motoc AGM; Boia ES
    Rom J Morphol Embryol; 2017; 58(2):371-376. PubMed ID: 28730220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful Treatment of Hypokalemic Rhabdomyolysis Caused by a Pancreatic VIPoma: A Case Report.
    Ramirez S; Lytle M; Togores E; Parellada J; Carlan SJ; Madruga M; Murillo-Alvarez RM
    Am J Case Rep; 2019 Nov; 20():1723-1727. PubMed ID: 31754090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnosis and treatment of pancreatic vasoactive intestinal peptide endocrine tumors.
    Song S; Shi R; Li B; Liu Y
    Pancreas; 2009 Oct; 38(7):811-4. PubMed ID: 19657309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VIPomas: an update in diagnosis and management in a series of 11 patients.
    Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Safioleas M; Mallas E; Polyzos A
    Hepatogastroenterology; 2005; 52(64):1259-65. PubMed ID: 16001675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WDHA (watery diarrhea, hypokalemia, achlorhydria) syndrome: clinical features, diagnosis, and treatment.
    Grier JF
    South Med J; 1995 Jan; 88(1):22-4. PubMed ID: 7817223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of chronic diarrhea caused by functional neuroendocrine neoplasms.
    Jensen RT
    Semin Gastrointest Dis; 1999 Oct; 10(4):156-72. PubMed ID: 10548409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Vipomas].
    Dupont C
    Ann Med Interne (Paris); 1984; 135(5):400-2. PubMed ID: 6091517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. All you need to know about VIPoma: Review on the latest studies.
    Karele EN
    Presse Med; 2024 Jun; 53(2):104222. PubMed ID: 38109967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pancreatic neuroendocrine tumors].
    Burgos L; Burgos ME
    Rev Med Chil; 2004 May; 132(5):627-34. PubMed ID: 15279151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological characteristics and risk factors for recurrence of well-differentiated pancreatic neuroendocrine tumors after radical surgery: a case-control study.
    Zhang P; Li YL; Qiu XD; Luo J; Shi YF; Sun YL; Su F; Qi ZR; Tan HY
    World J Surg Oncol; 2019 Apr; 17(1):66. PubMed ID: 30975157
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.